Plasma Fractionation Market Size Growth Analysis 2022
The global plasma fractionation market size was valued at USD 26,842.9 million in 2021 and is poised to grow at a significant CAGR of 6.8% during the forecast period 2022-28. Plasma fractionation refers to the process of separation, extraction, and purification of plasma. Human plasma contains the large variety of proteins, however, only a few of these proteins are help in producing therapeutic plasma products. Plasma is used in prevention and treatment of various life-threatening diseases caused by trauma, immunologic disorders, and infections. The plasma fractionation process is majorly used in treating protein deficiency condition in healthcare applications. The proteins extracted from the plasma are majorly categorized into three main classes: immunoglobulins which are useful in the treatment of autoimmune disorders and increasing the immune response of the body, clotting factors which are help in treatment of blood disorders such as haemophilia, and the albumins which are useful in conditions of decreased albumin levels or during fluid loss. Plasma fractionation process is carried by different criteria such as solubility of the products, and their physical and chemical conditions such as ionic strengths, pH levels, and temperature, etc.
View detailed report description here https://precisionbusinessinsights.com/market-reports/global-plasma-fractionation-market/
Plasma fractionation market expected to grow at significant rate over the forecast period due to rise in the incidence of immune and bleeding disorders, increase in the use of alpha-1 antitrypsin and immunoglobulin, rise in prevalence of Alpha-1 Antitrypsin Deficiency (AATD), emphysema, and haemophilia. In addition, development in plasma techniques and plasma utilization are the key factors expected to boost the plasma fractionation market. However, high cost for the plasma products, adverse effects associated with the plasma fractionation products, lack of reimbursement policies, stringent regulatory policies, and increase in the recombinant coagulation factors might hinder the growth of plasma fractionation market over the forecast timeframe.
The global plasma fractionation market segmentation:
- By Product Type: Albumin, Immunoglobulin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Fractionation Products
- By Application: Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others
- By End Users: Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories
Geographically, global plasma fractionation market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the global plasma fractionation market followed by Europe and Asia-Pacific. Europe is the second largest region for global plasma fractionation market due to the rise in aging population and increase in the prevalence of chronic diseases.
Request sample report https://precisionbusinessinsights.com/request-sample/?product_id=15896
Some of the major players working in plasma fractionation market, which include Grifols S.A (Spain), CSL Ltd. (Australia), Shire (Ireland, Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (OGEL GmbH) (Germany), LFB S.A (France), Sanquin (Netherlands)
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian